You are here

hematology

[podcast]Brukinsa approval raises BeiGene’s hematology profile

Medical Marketing and Media

Wed, 03/20/24 - 09:38 pm

Takeda grabs late-stage hematology drug from Protagonist

Pharmaphorum

Thu, 02/1/24 - 11:20 am

Protagonist Therapeutics

polycythemia vera

Sobi agrees to buy CTI BioPharma for $1.7bn

Pharmaceutical Technology

Thu, 05/11/23 - 09:50 am

Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas

BioSpace

Wed, 04/26/23 - 10:24 am

cardiovascular disease

Layoffs loom as Takeda trims early-stage efforts in AAV gene therapy, rare hematology

Fierce Biotech

Fri, 04/7/23 - 01:45 pm

BMS and ConcertAI launch digital trial solution for oncology

Clinical Trials Arena

Fri, 09/30/22 - 10:54 am

Bristol Myers Squibb

clinical trials

TG adds a multiple sclerosis string to its bow

EP Vantage

Fri, 12/11/20 - 11:07 am

TG Therapeutics

multiple sclerosis

Bristol Myers Squibb hematology chief talks COVID-19 challenges, opportunities in blood cancer therapies

Fierce Pharma

Tue, 10/13/20 - 09:57 pm

Bristol-Myers Squibb

Forty Seven bucks the trend

EP Vantage

Thu, 01/23/20 - 12:02 pm

colorectal cancer

Jazz, ImmunoGen partner on hematology, oncology drug development

BioPharma Dive

Wed, 08/30/17 - 11:46 pm

Jazz Pharmaceuticals

drug development

Roche's Hematology Franchise Almost 100% Protected From Biosimilars

Seeking Alpha

Fri, 05/27/16 - 10:59 pm

Biogen scouting for new hematology programs to buy, license

Fierce Biotech

Mon, 03/7/11 - 10:50 am

Novartis Buys U.S. Cancer Lab for $470 Million

Mon, 01/24/11 - 03:24 pm

Novel Test Following Prostate Surgery Could Detect Cancer Recurrence Earlier

Thu, 09/30/10 - 07:53 am

prostate cancer

13 Biotechs to Watch for at Hematology Conference

Seeking Alpha

Mon, 11/30/09 - 09:32 am

ONYX Pharmaceuticals

Seattle Genetics

Aeterna Zentaris

Ariad Pharmaceuticals

Incyte to license 2 hematology drugs to Novartis

Marketwatch

Wed, 11/25/09 - 05:56 am